thiotepa has been researched along with Thrombocythemia, Essential in 2 studies
Thiotepa: A very toxic alkylating antineoplastic agent also used as an insect sterilant. It causes skin, gastrointestinal, CNS, and bone marrow damage. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), thiotepa may reasonably be anticipated to be a carcinogen (Merck Index, 11th ed).
Thrombocythemia, Essential: A clinical syndrome characterized by repeated spontaneous hemorrhages and a remarkable increase in the number of circulating platelets.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Case, DC | 1 |
| Garfield, DH | 1 |
2 other studies available for thiotepa and Thrombocythemia, Essential
| Article | Year |
|---|---|
Therapy of essential thrombocythemia with thiotepa and chlorambucil.
Topics: Adult; Aged; Bone Marrow; Chlorambucil; Dose-Response Relationship, Drug; Female; Hematocrit; Humans | 1984 |
Acute erythromegakaryocytic leukaemia after treatment with cytostatic agents.
Topics: Adenocarcinoma; Aged; Bone Marrow Diseases; Erythrocytes; Humans; Leukemia; Lung Neoplasms; Male; Me | 1970 |